Edition:
United Kingdom

Michael Erman

Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations

29 Jun 2020

Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the next three months.

Hard-hit U.S. states 'surge' hospital intensive care beds as ICU wards fill up

27 Jun 2020

Some Texas hospitals are running out of intensive care unit (ICU) beds for COVID-19 patients, turning to surge capacity that they expect will let them handle rising virus cases for another couple of weeks.

Hard-hit U.S. states 'surge' hospital intensive care beds as ICU wards fill up

26 Jun 2020

Some Texas hospitals are running out of intensive care unit (ICU) beds for COVID-19 patients, turning to surge capacity that they expect will let them handle rising virus cases for another couple of weeks.

U.S. demand outstripping supply of steroid treatment for COVID

25 Jun 2020

NEW YORK Soaring hospital demand for the steroid dexamethasone, which British researchers say significantly reduces mortality among severely ill COVID-19 patients, is outstripping supply of the drug, but hospitals have so far been able to treat patients out of their inventories, according to Vizient Inc, a drug buyer for about half of U.S. hospitals.

U.S. hospitals in hard hit regions step up use of steroids on sickest COVID-19 patients

19 Jun 2020

NEW YORK Several U.S. hospitals in states with fresh surges of COVID-19 cases have started treating their sickest patients with dexamethasone rather than await confirmation of preliminary results of a study by British researchers, who said the inexpensive steroid saves lives.

U.S. hospitals in hard hit regions step up use of steroids on sickest COVID-19 patients

19 Jun 2020

NEW YORK Several U.S. hospitals in states with fresh surges of COVID-19 cases have started treating their sickest patients with dexamethasone rather than await confirmation of preliminary results of a study by British researchers, who said the inexpensive steroid saves lives.

U.S. hospitals in hard hit regions step up use of steroids on sickest COVID-19 patients

19 Jun 2020

NEW YORK, June 19 Several U.S. hospitals in states with fresh surges of COVID-19 cases have started treating their sickest patients with dexamethasone rather than await confirmation of preliminary results of a study by British researchers, who said the inexpensive steroid saves lives.

Show me the data: U.S. doctors skeptical of reported COVID breakthrough

17 Jun 2020

The report on Tuesday of a powerful treatment for the new coronavirus brought skepticism along with optimism among U.S. doctors, who said the recent withdrawal of an influential COVID-19 study left them wanting to see more data.

Show me the data: U.S. doctors skeptical of reported COVID breakthrough

16 Jun 2020

June 16 The report on Tuesday of a powerful treatment for the new coronavirus brought skepticism along with optimism among U.S. doctors, who said the recent withdrawal of an influential COVID-19 study left them wanting to see more data.

Fears of second U.S. coronavirus wave rise on worrisome spike in cases, hospitalizations

12 Jun 2020

About half a dozen states including Texas and Arizona are grappling with a rising number of coronavirus patients filling hospital beds, fanning concerns that the reopening of the U.S. economy may spark a second wave of infections.

World News